Institutions / Exome Asset Management LLC
Exome Asset Management LLC
CIK 2011932 · Institution · as of Dec 31, 2025
Portfolio value
$202.43M
Positions
53
As of
Dec 31, 2025
Top holdings
Dec 31, 2025View all 53 →
| Company | Value | % of portfolio |
|---|---|---|
| Praxis Precision Medicines, Inc. | $17.13M | 8.5% |
| Cogent Biosciences, Inc. | $10.85M | 5.4% |
| Guardant Health, Inc. | $10.03M | 5.0% |
| Ionis Pharmaceuticals Inc | $9.22M | 4.6% |
| ELI LILLY & Co | $8.44M | 4.2% |
| Cytokinetics Inc | $7.93M | 3.9% |
| Wave Life Sciences Ltd | $7.17M | 3.5% |
| Vera Therapeutics, Inc. | $6.30M | 3.1% |
| BridgeBio Pharma, Inc. | $6.17M | 3.1% |
| Elevance Health Inc | $6.03M | 3.0% |
| Astrazeneca PLC | $5.26M | 2.6% |
| Jazz Pharmaceuticals PLC | $4.50M | 2.2% |
| Natera, Inc. | $4.27M | 2.1% |
| Immunovant, Inc.IMVT | $4.03M | 2.0% |
| Universal Health Services Inc | $3.84M | 1.9% |
| United Therapeutics Corp | $3.74M | 1.8% |
| Agios Pharmaceuticals, Inc. | $3.73M | 1.8% |
| Disc Medicine, Inc.IRON | $3.71M | 1.8% |
| Intuitive Surgical Inc | $3.60M | 1.8% |
| Glaukos Corp | $3.55M | 1.8% |
| Enliven Therapeutics, Inc.ELVN | $3.42M | 1.7% |
| Celcuity Inc.CELC | $3.42M | 1.7% |
| Apellis Pharmaceuticals, Inc. | $3.41M | 1.7% |
| Travere Therapeutics, Inc. | $3.40M | 1.7% |
| Dexcom Inc | $3.33M | 1.6% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.